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AB5 toxins are composed of an enzymatic A subunit
that disrupts cellular function associated with a pen-
tameric B subunit required for host cell invasion.
EcxAB is an AB5 toxin isolated from clinical strains
of Escherichia coli classified as part of the cholera
family due to B subunit homology. Cholera-group
toxins have catalytic ADP-ribosyltransferases as
their A subunits, so it was surprising that EcxA did
not. We confirmed that EcxAB self-associates as a
functional toxin and obtained its structure. EcxAB
is a prototypical member of a hybrid AB5 toxin family
containing metzincin-type metalloproteases as their
active A subunit paired to a cholera-like B subunit.
Furthermore, EcxA is distinct from previously char-
acterized proteases and thus founds an AB5-associ-
ated metzincin family that we term the toxilysins.
EcxAB provides the first observation of conserved
B subunit usage across different AB5 toxin families
and provides evidence that the intersubunit interface
of these toxins is far more permissive than previously
supposed.
INTRODUCTION
AB5 toxins are key virulence factors produced by a range of path-
ogenic bacteria known to be the causative agents of diseases
such as cholera, whooping cough, and dysentery. Each AB5 pro-
tein consists of two components: a pentameric B subunit that
targets eukaryotic cells by binding to glycans located at the
cell surface and a catalytic A subunit that disrupts host cellular
function following internalization. Different families of AB5 toxins
have been categorized according to the level of sequence con-
servation in the A and B subunits as well as the A subunit’s enzy-
matic activity. Four families are currently known: the Shiga toxins
inhibit protein synthesis using a ricin-like catalytic subunit (Fraser
et al., 1994), the pertussis and cholera toxin groups carry unre-
lated ADP-ribosyltransferases, and SubAB cytotoxin acts as aStructure 21, 2003–20subtilase-like serine protease (Beddoe et al., 2010). The B sub-
units of each family share structural, but not sequence, homol-
ogy, while the A subunits are only related within a family (Merritt
and Hol, 1995). Despite structural conservation among their B
subunits, each AB5 protein targets its own cell subpopulations,
as minor binding site differences can drastically alter host recep-
tor specificity (Merritt et al., 1997). Moreover, multiple ligand
binding sites within the B subunit can also serve to broaden
the target cell specificity (Holmner et al., 2007, 2011). Additional
complexity is also present within the pertussis toxin whose B
subunit gene has expanded and diverged, resulting in an atypical
heteropentamer (Stein et al., 1994), so despite the similarities
inherent in these toxins, the underlying mechanisms of host
cell recognition and disruption can be disease specific.
The pathway of cellular disruption by the cholera AB5 protein
has been well defined and stands as a canonical mechanism
of AB5 action (De Haan and Hirst, 2004). The toxin’s B subunit
orchestrates the initial stages of this complex invasive process.
Briefly, each B subunit within the pentamer can bind glycolipid
headgroups such as those of monosialotetrahexosylganglioside
(GM1) at the plasma membrane instigating endocytosis and
migration of the holotoxin through the trans-Golgi network to
the endoplasmic reticulum (ER) via retrograde trafficking. The
A subunit then undergoes proteolytic cleavage into two disul-
fide-linked sections: a larger enzymatic A1 domain and an A2
domain interfaced with the B5 pentamer. Finally, this disulfide
link is actively reduced, permitting A1 domain dissociation and
its retrotranslocation to the cytosol where its ADP-ribosyltrans-
ferase activity corrupts regulation of fluid secretion.
The cholera-like toxins are the largest subgroup of AB5 pro-
teins including both the archetype cholera toxin (Ctx) and related
heat-labile enterotoxins (LT-I and LT-II). Genes encoding two
novel cholera-family B subunits were identified and character-
ized within clinical isolates of Citrobacter freundii and Escheri-
chia coli derived from diarrheal patients (Karasawa et al.,
2002). These new toxin B subunits were, respectively, named
CfxB and EcxB. When the structure of CfxB was solved, it
confirmed the placement of these proteins within the cholera
group (Jansson et al., 2010). The B subunits of all previously
studied toxins from the cholera group pair with a related series
of A subunits, a conserved family of ADP-ribosyltransferases.
In contrast, the genes for CfxB and EcxB are located13, November 5, 2013 ª2013 Elsevier Ltd All rights reserved 2003
Table 1. Data Collection, Processing, and Refinement Statistics
Statisticsb Apo EcxAB GM1:EcxAB
Resolution limits (A˚)a 39.5–1.86
(1.9–1.86)
34.3–1.80
(1.9–1.80)
X-ray wavelength (A˚) 0.9537 0.9537
Space group P6522 P6522
Unit-cell parameters (A˚) 120.7, 120.7, 274.3 120.4, 120.4, 273.4
No. of observationsa 1,157,466
(169,463)
790,884
(102,891)
No. of unique reflectionsa 992,067 (14,280) 107,527 (15,448)
Mosaicity 0.7 0.4
Completeness (%)a 99.9 (100) 99.5 (99.5)
Multiplicity 11.9 7.4 (6.7)
Rp.i.m. (%)
a,b 6.2 (46.7) 4.3 (38.8)
<I/s(I) >a 9.2 (1.6) 11.7 (2.0)
R factor (%)c 17.5 17.8
R-free (%)d 20.8 19.8
Isotropic B factor (Zn) 37.2 (43.9) 37.6 (41.5)
Number of atoms
Protein 6159 6169
Water (Zn) 608 (1) 573(1)
GM1 n/a 340
rmsd bonds (A˚) 0.007 0.007
rmsd angles () 1.1 1.1
MOLPROBITY results (%)
Ramachandran favored 99.7 99.7
Ramachandran outliers 0.3 (Gly-281) 0.3 (Gly-281)
aValues in parentheses refer to the highest resolution bin.
bRp.i.m. = S(hkl) [1/(N-1)]
1/2 Si j Ii(hkl)  < I(hkl) > j / S(hkl) Si < I(hkl) > where N is
the redundancy of the hkl reflection.
cRfactor = (S j jFoj  jFcj j) / (S jFoj) - for all data except as indicated in foot-
note d.
dFive percent of data were used for the Rfree calculation (see footnote c).
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EcxAB Is a Metzincin Cholera Family AB5 Toxindownstream of their respective cfxA and ecxA genes, neither of
which encode proteins with homology to any previously studied
AB5 protein (Jansson et al., 2010; Karasawa et al., 2002).
Instead, the A subunits aligned with a group of uncharacterized
bacterial proteins with weak homology to zinc-dependent
metzincin metalloproteinases (Jansson et al., 2010) (20%–
25% sequence identity to human matrix metalloproteinase 2
[MMP2]).
In the present study, we have determined the X-ray crystal
structure of the entire EcxAB holotoxin to 1.86 A˚ resolution in
both apo- and receptor-bound forms. We confirm that EcxA
and EcxB pair together and thus represent a member of the
AB5 toxin superfamily. Furthermore, we demonstrate that EcxA
is an endopeptidase that stands as a founding member of a
family of metzincin metalloproteases, that of the toxilysins,
deserving further characterization. Intriguingly, this EcxA subunit
docks with its cholera-like EcxB pentamer through an A2
domain, involving a redox-switching 310 helix. EcxAB and CfxAB
thus represent founding members of a unique AB5 family hybrid
that comprises B subunits very similar to that of cholera toxin but
pair through an entirely different mechanism to an unrelated2004 Structure 21, 2003–2013, November 5, 2013 ª2013 Elsevier Ltdcatalytic A subunit. The EcxAB structure presented here demon-
strates a significant level of binding plasticity within cholera-like
toxin B subunits. Such binding plasticity may allow a plethora of
possible A2 domains to bind, increasing AB5 toxin evolvability,
possibly having implications for the time frames over which path-
ogenic bacteria and their bacteriophages have been or are able
to adapt.
RESULTS
EcxAB, a Novel AB5 Toxin
The Ecx and Cfx operon structures contain conserved cholera
toxin-like B subunit genes (Jansson et al., 2010) downstream
of novel A subunit genes (Karasawa et al., 2002). EcxA and
CfxA share 78% sequence identity to each other but are not
related to ADP-ribosyltransferases such as CtxA or, indeed,
any known AB5 toxin subunit. Instead, they contain a
HExGHxxGxxH motif characteristic of the metzincin family of
metalloproteases (Tallant et al., 2010) but only 10–20 conserved
residues outside this sequence. We have recently shown that
coexpression of EcxA and EcxB results in the formation of a
stable heterohexameric protein complex (Ng et al., 2013), con-
firming that EcxAB represents an AB5 toxin. To ascertain
whether EcxA truly was a metalloprotease as well as under-
standing the nature of the EcxAB holotoxin’s intersubunit inter-
action mechanism, we sought to determine its structure.
Following optimization, crystals of the purified EcxAB holotoxin
could be grown that diffracted to 1.86 A˚ resolution. An initial
model was obtained using CtxB (Merritt et al., 1997) as a molec-
ular replacement model, yielding clear electron density for the
remaining A subunit that allowed it to be built (see Experimental
Procedures and Table 1 for details). The final model is largely
complete (residues 20–267 and 20–118 for EcxA and B sub-
units), with only two breaks in electron density corresponding
to flexible loops within the A subunit (residues 68–71 and
103–107). The EcxAB crystals contain a single heterohexameric
AB5 complex in the asymmetric unit (63% solvent). The struc-
ture has a global organization similar to other AB5 toxins (Fig-
ure 1), with EcxB adopting a homopentameric ring-shaped
assembly. The unique Ecx A subunit is composed of two
domains, A1 and A2, linked together via a disulfide bond
between residues Cys-208 and Cys-271. Similar, but not struc-
turally homologous, A1-A2 linking disulfides are found in other
AB5 toxins. The C-terminal A2 domain contains an eight-
amino-acid 310 helix that penetrates into the central pore of
the B subunit (Figures 2B and 3).
The Cholera-like EcxB Pentamer
Each monomer of EcxB possesses six antiparallel b strands and
two a helices forming an oligonucleotide and oligosaccharide
binding fold (OB fold). As in other cholera-family toxins, helix 1
is anchored to b strand 5 via a disulfide bond (Cys-9 to Cys-
86) (Jansson et al., 2010; Merritt et al., 1995; van den Akker
et al., 1996). There are five copies of EcxB within the asymmetric
unit that, despite being under the influence of different packing
constraints, are essentially identical. We label the five EcxB
monomers EcxB1 to B5, and they homooligomerize to form a
typical AB5-pentameric ring (see Figure 1B). The structure of
each EcxB monomer and its orientation within this pentamericAll rights reserved
Figure 1. Overall Structure of the EcxAB Holotoxin
(A) Displays the global organization of the EcxAB holotoxin in a cartoon repre-
sentation. ForEcxA, secondary structural elements are labeledandcoloredwith
helices in red and b strands in yellow. TheA2 segment is highlighted in pink, with
the A1-linking disulfide also shown. Three of the five EcxB subunits are colored
in blue, tan, and light blue. EcxB3 and B4 are not displayed in this orientation.
Dottedgreen lines represent loop regionsunable tobebuilt intoelectrondensity.
(B) The organization of the EcxAB pentamer is seen clearly from beneath the
molecule utilizing the same coloring as in Figure 2A. EcxB3 and B4 are shown in
green and orange.
See also Figure S1 and 3D Molecular Model S1.
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Structure 21, 2003–20assembly are almost identical to those of other cholera family
toxins. The closest structural homologs are CfxB (86%
sequence identity, root-mean-square deviation [rmsd] of 0.8 A˚
over 451 Ca) (Jansson et al., 2010), CtxB (63% sequence iden-
tity, rmsd of 0.5 A˚ over 515 Ca) (Merritt et al., 1997), and the
heat-labile toxin B subunits (66% sequence identity, 0.5 A˚ over
518 Ca with LT-IIb) (van den Akker et al., 1996; see Figure 1
and Figure S1 available online).
Glycan Binding by EcxB
To gain access to host cells, AB5 toxins bind glycan receptors on
the host surface via the B pentamer. The residues making up the
cholera toxin’s ganglioside GM1 (Galb3GalNAcb4(NeuAca3)
Galb4Glcb1Cer) binding site are largely identical in EcxB,
suggesting a conserved mechanism of cell targeting. Accord-
ingly, we sought to understand the receptor specificity of EcxB
via glycan array analysis performed at the Consortium of
Functional Glycomics (CFG). EcxB showed a high degree of
binding specificity for the glycan moiety of ganglioside GM1
(Galb3GalNAcb4(NeuAca3)Galb4Glcb1Cer) and its fucosylated
derivatives but very little binding to other glycans (Table 2).
This is not surprising, as the close homologs CtxB and CfxB
also bind GM1. CfxB had previously been shown to have an
affinity for neolacto-(Galb4GlcNAcb-) and blood group A type
2-(GalNAca3(Fuca2)Galb4GlcNAc) terminated glycans (Jansson
et al., 2010). EcxB showed no affinity for these glycans, suggest-
ing amore cholera-like glycan-binding site. To ascertain whether
this was the case, we transferred EcxAB crystals into a solution
containing the GM1 pentasaccharide head group prior to
freezing, after which a 1.86 A˚ data set was collected (see Table
1 for data collection and refinement statistics). The overall struc-
ture of EcxAB is largely unchanged by GM1 binding; those
sections of EcxA furthest away from EcxB are not as well defined
as in the unliganded structure. Correspondingly, the s4 s5 loop;
the s7, s8, and s9 b sheet; and helix 4 have higher B factors
following refinement. In contrast the remainder of EcxA and the
B pentamer are clearly visible with calculated omit maps
showing good density for GM1 in all five B subunit binding sites
(see Figure 4A). Electron density is clear for each sugar moiety in
all sites, allowing five independent copies of the ligand to be built
and their interactions to be defined with a high degree of
confidence.
The glycan binding site of EcxB is largely equivalent to that of
CtxB; all residues forming direct hydrogen bonds with GM1 are
conserved (see Figures 4A and 4B). The similarities of the glycan
binding sites in EcxAB andCtxAB suggest that they target similar
cellular subtypes. Comparisons made between cholera and
heat-labile toxins have shown that minor differences within the
glycan binding sites nevertheless leads to substantial effects
on specificity (Holmner et al., 2011); the affinity of EcxAB for
GM1 was thus determined by surface plasmon resonance
(SPR) (Figure 4C). A kinetic analysis of EcxAB binding as
measured by SPR could not be modeled with an appropriate
fit due to the multivalent nature of the EcxB pentamer. However,
an apparent KD was determined by pseudoequilibrium analysis,
a method used for other AB5 toxins in previous publications. The
apparent dissociation constant, KD, of EcxAB for binding to GM1
is 32 ± 2 nM, and as expected, given the level of sequence iden-
tity within their binding sites, is similar to that published for CfxB13, November 5, 2013 ª2013 Elsevier Ltd All rights reserved 2005
Figure 2. The EcxA Endopeptidase Domain
and Its Comparison with MMP2
(A) The structure of the catalytic sections of the
EcxA subunit is shown highlighting the bound zinc
ion and proteolytic active site. Secondary struc-
tural elements are labeled and colored with helices
in red and b strands in yellow. The metzincin NTD
module is deemphasized by being displayed as
partially transparent.
(B) For comparison, an identical alignment of the
catalytic CTD module of the human matrix metal-
loprotease 2 is shown. Colored sections highlight
the catalytically important residues discussed in
text and are labeled and colored accordingly (PDB
ID 1EAK).
(C) Sequence of EcxA shown above that of CfxA;
the extent of the various secondary structure ele-
ments are depicted with arrows and helices. The
secretion tag and residues unable to be built into
the electron density are in gray italics. Catalytically
important residues are bold and colored as
labeled in (B). The A2 section is in pink, and the
disulfide cystines are in red.
See also Figure S3.
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EcxAB Is a Metzincin Cholera Family AB5 Toxin(Jansson et al., 2010) and CtxB (MacKenzie et al., 1997; Masser-
ini et al., 1992). While the nature of their GM1 binding sites ap-
pears conserved, CfxB binds to blood group A type 2 antigens
(Jansson et al., 2010) while glycan arrays indicate that EcxB
does not. Such antigens bind the B subunit of the heat-labile
toxin using an alternate binding site on the circumferential
edge of the pentamer (Holmner et al., 2007). Most residues mak-
ing up this novel antigen site in LT-IB are conserved across both
CfxB and EcxB, including a tyrosine and threonine thought to be
important for recognition; further work is needed to confirm dif-
ferences in blood antigen specificity across the cholera-group
B subunits that will aid an analysis of the determinants for this
secondary ligand site.
The Unique A Subunit—EcxA
The EcxA subunit is a globular protein consisting of nine a heli-
ces, one 310 helix, and three antiparallel b sheets containing 12
strands in total (see Figures 1, 2A, and 2C). While EcxA and
CtxA share no sequence similarity, there remained the possibility
that they could share structural homology. This was not the case;
however, a structure-based search of the Protein Data Bank
(PDB) using ‘‘Fold’’ (Krissinel and Henrick, 2004) identified the
closest known homolog being that of an inactive form of human
pro matrix metalloprotein 2 (Protein Data Bank [PDB] ID, 1EAK;
rmsd of 2.1 A˚ over 116 of 282 Ca, 19 of the 116 residues are
conserved). The degree of structural conservation is low, and2006 Structure 21, 2003–2013, November 5, 2013 ª2013 Elsevier Ltd All rights reservedEcxA could equally well be described as
having homology to the catalytic cores
of a number of metzincin proteases.
Indeed, the majority of conservation be-
tween EcxA and MMP2 exists within their
respective zinc-binding motifs (residues
HExGHxxGxxH; Figure 2 and Figure S3).
Despite low sequence similarity between
EcxA and MMP-2, the catalytic sectionsof the fold are largely conserved, implying that EcxA is indeed
a metzincin protease (Figure 2). This is not without precedent;
an unrelated serine protease makes up the enzymatic A subunit
of the subtilase cytoxin AB5 family (Paton et al., 2004).
The structural core of EcxA resembles that of other metzincin-
type metalloproteases. This fold is described as consisting of an
upper subdomain prior to the consensus motif and a lower
C-terminal subdomain following it (Tallant et al., 2010); this rough
division results in the subdomains lying on either side of the pep-
tide-binding cleft overlaying the active-site helix (h6 in EcxA). In
EcxA, this classical metzincin fold division is confused, as N-ter-
minal residues form an integral part of the C-terminal subdomain
structure. The lower subdomain of EcxA could be described as
the base sitting atop the B subunits; this consists of one of the
b sheets (s1, s10, s11, s12, s2), a backing helix (h8), an N-termi-
nal helix (h1), and several long loops (elements shown as partially
transparent in Figure 2A). The upper subdomain of EcxA, like
other metzincins, contains most of the catalytic machinery: the
active-site helix provides two of three zinc-coordinating histi-
dines (H179EIGH183) and the proposed catalytic base Glu-180
(Figure 2). The third metal-coordinating histidine, His-189, arises
from the loop immediately C terminal to helix 6. Electron density
provides clear evidence for a metal ion coordinated by these
three histidines in EcxA (greater than 10 s peaks in omit and
anomalous difference Fourier maps). This ion is modeled as
zinc due to a peak in X-ray fluorescence scans and homology
Figure 3. Interactions Making Up the EcxA-
B Interface
(A) Top: overview of the B subunit pentameric
structure with inserted A2 helices shown for the
cholera toxin (Ctx) and Ecx. Bottom: smaller scale
views in the same orientation for Shiga toxin (Stx),
pertussis toxin (Ptx), and the E. coli heat-labile
endotoxin I (LTI). Coloring is as in Figure 2A.
(B) The hydrophobic intersubunit interaction
interface showing the EcxA helix 9 and helix A2 in
pink. EcxA residues are labeledwith italic font, and
EcxB residues are labeled with standard roman
font according to the color of their originating
subunit. The Cys-208-Cys-271 redox switch di-
sulfide is shown at the top.
(C) The hydrogen bonds EcxAmakes to EcxB3 and
B4 via its N-terminal residues and s11 loop are
shown.
See also Figure S2.
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EcxAB Is a Metzincin Cholera Family AB5 Toxinwith the catalytic sites of other metzincins. The ion has a dis-
torted square pyramidal coordination to the three-histidine’s
epsilon nitrogens and two water molecules. Matrix metallopro-
teinase metzincins frequently bind other metal ions via their
acidic S loop, an area of the protease involved in substrate
recognition. In contrast, EcxA possesses only its catalytic zinc
ion, having a more abridged loop at this site (see Figures 2A
and 2B), and no further unmodeled peaks are observed in the
electron density. An absence of noncatalytic metal ions in
EcxA is one of several features conserved amongMMPsmissing
in this protein. On the basis that flexible regions of the protein
may confuse structural searches, we expanded our comparison
of the EcxAmetzincin fold to encompass a broader range of such
proteases.
The metzincin clan of metalloproteases is found in all domains
of life. It is described in terms of lineages of closely related
proteins including the MMPs, astacins, serralysins, adamaly-
sins/ADAMs/reprolysins, snapalysins, leishmanolysins, pappa-
lysins (Gomis-Ru¨th, 2009), and the more recently characterized
fragilysins, archaemetzincins, and cholerilysins. Distinguishing
features of metzincin endopeptidases include a methionine-
containing turn required for the structural integrity of the cata-
lytic zinc-binding site and the subsequent substrate-bindingStructure 21, 2003–2013, November 5, 2013 ªloop (Tallant et al., 2010). In MMPs,
this Met turn is directly C terminal to helix
6 (see Figure 2B). EcxA, instead, has a
large loop inserted at this point that
delves toward the B pentamer, with b
strands s10 and s11 extending the lower
subdomain’s b sheet before returning
29 residues later to form a Met turn. The
returning s11 loop is important as it
contains Cys-208, which participates in
the A subunit’s only disulfide bond.
AB5 toxins frequently contain a redox-
sensing disulfide whose reduction inside
the host cell acts as a switch to promote
subunit dissociation and A subunit
activation. As discussed later, in Ecx,this disulfide is in an unusual position directly above the B
subunits’ pentameric pore. When compared with other metzin-
cins, EcxA thus contains structural elements inserted within its
catalytic machinery that extend to interface with the toxin B
subunits. The intact nonreduced EcxAB holotoxin showed no
proteolytic activity in a nonspecific small scale test (see Fig-
ure S4D). Active metzincins have a hydrophobic cavity adjacent
to the catalytic zinc ion. A large aromatic residue within the
substrate inserts into the cavity, p-stacking with a metal-coordi-
nating histidine while forming backbone and side chain inter-
actions with a conserved tyrosine within the substrate loop.
In the EcxAB structure, the substrate loop of EcxA does
not adopt an active conformation; what should be a hydro-
phobic pocket next to the zinc ion is instead large and polar.
The missing pocket is due to the conformation of the EcxA
substrate-binding loop; although a tyrosine is present, instead
of forming one wall of the hydrophobic pocket, it is oriented
away from the active site and toward the B pentamer (see Tyr-
224 and pink substrate loop in Figure 2A). The B-subunit-bound
form of EcxA may thus represent that of a proenzyme, the
correct folding of the A subunit’s catalytic machinery potentially
requiring its dissociation from the pentameric ring following
cellular delivery.2013 Elsevier Ltd All rights reserved 2007
Table 2. Glycan Array Analysis of EcxB
Glycan No. Structure
Mean Relative
Fluorescence Units
Coefficient of
Variation (%)
141 Galb1-3GalNAcb1-4(Neu5Aca2-3)Galb1-4Glcb-Sp0a (GM1) 7,112 12
63 Fuca1-2Galb1-3GalNAcb1-4(Neu5Aca2-3)Galb1-4Glcb-Sp9a (Fucosyl-GM1) 2,954 6
62 Fuca1-2Galb1-3GalNAcb1-4(Neu5Aca2-3)Galb1-4Glcb-Sp0 (Fucosyl-GM1) 1,798 30
297 Galb1-3Galb1-4GlcNAcb-Sp8a 707 6
139 Galb1-3GalNAcb-Sp8 231 67
231 Neu5Aca2-3(Neu5Aca2-3Galb1-3GalNAcb1-4)Galb1-4Glcb-Sp0 214 42
Data are presented for a selection of 6 of the 511 glycans present on the array; a histogram plot of the entire array is presented in Figure S4E. Complete
data sets are available at http://www.functionalglycomics.or/glycomics/publicdata/selectedScreens.jsp. Data are for quadruplicate array spots.
aSp0, Sp8, and Sp9 designate CH2CH2NH2, CH2CH2CH2NH2, and CH2 CH2CH2CH2CH2NH2 linkers, respectively.
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Proteins within eachmetzincin family share similar ancillary addi-
tions to their core metalloprotease fold arising out of conserved
family-specific sequences (Gomis-Ru¨th, 2009). One such char-
acteristic region occurs within the loop spanning between the
zinc-binding HExGHxxGxxH motif and the subsequent
conserved methionine turn, residues important for enzymatic
activity and substrate specificity (Gomis-Ru¨th, 2003). The
sequence of this region shows considerable homology among
family members to the point of ‘‘family-specific’’ residue posi-
tions being defined C terminal to the third histidine and two res-
idues N terminal to the methionine turn. The remainder of the
zinc-binding/Met-turn sequence is also used to help identify
members of a particular metzincin family, even if they otherwise
have low homology outside this region. This loop within EcxA
(residues 179–218; Figure 2C) is elongated through insertion of
the s10, s11 b strands and did not immediately resemble previ-
ously defined metzincin family sequences (Gomis-Ru¨th, 2009).
We thus compared the structure of EcxA to metzincins from
each major family. This was done with particular focus on met-
zincins with large loops within their zinc-binding/Met-turn
sequence including the astacins, serralysins, pappalysins, chol-
erilysins, and leishmanolysins but also the snapalysins because
of their single conserved cysteine within this loop (Gomis-Ru¨th,
2009). The structure of the EcxA zinc-binding/Met-turn loop
diverges from that observed in other metzincins; it is part of
the B-pentamer-interacting loop that contains half of the AB5
redox switch and extends the lower subdomain’s b sheet, a pen-
tamer-interacting b sheet that is one of several features marking
the EcxA metzincin fold as significantly different from previously
observed structures. Other aspects include the insertion of two
short helices (h4 and h5) N terminal to the active-site helix that
also line one end of the EcxA substrate cleft and a two-stranded
s4 s5 b sheet wrapping around the back of themolecule (see Fig-
ure 2A). A lack of sequence conservation and the sheer disparity
between the EcxA structure and previously solved metzincins,
as well as its exclusive association as part of a heterohexameric
AB5 toxin, would attest that this protein stands as a prototype for
a family of metzincin proteases, a family that we propose to call
the toxilysins. Thismetzincin family includes EcxA andCfxA-type
proteins (e.g., BAC16523,WP_016231354,WP_001575760, and
BAC16521) and, potentially, a number of other related proteins
that are yet to be fully characterized. We are working to define
the characteristic sequence determinants and substrate speci-2008 Structure 21, 2003–2013, November 5, 2013 ª2013 Elsevier Ltdficity for the family but would expect the zinc-binding/Met-turn
sequence to resemble H-E-x-x-H-x-x-G-x-x-H-N-[16]-C-
[6]-P-S/A-I/L-M. The potential length of this loop, the necessity
of the conserved asparagine, and the position of the redox-
switch cysteine are all aspects, for some variability in other family
members could be expected. It will next be important to charac-
terize the substrates, activation mechanism, and sequence de-
terminants of the toxilysin family of proteases.
The Ecx Oligomerization Interface
The B subunits of the AB5 toxins oligomerize to form stable pen-
tameric rings that bind to their respective A subunits. The OB
folds of the toxins’ B subunit are well conserved, their oligomer-
ization yielding a central pore 15 A˚ in diameter symmetrically
lined with five copies of the residues from one face of the B sub-
units’ longest h2 helix. One of the stabilizing features of the
mature holotoxins is the insertion of the A subunit’s C-terminal
A2 helix directly into the central pore of the pentamer. The resi-
dues lining the pore vary in different proteins, but the two ends
can generally be ascribed distinct characteristics (see Figure S2);
the end directly interfacing with the A subunit is frequently hydro-
phobic, presenting a cylindrical interaction surface for the
respective toxin’s A2 helix (Tinker et al., 2003). In contrast, the
membrane-proximal side of the channel is more often charged
or polar in character.
The A2 helices of different AB5 toxin families are unrelated.
They vary in overall length and angle of approach to the pore
(Figure 3), but the segment contained within the pentameric
ring is globally similar. An archetypical toxin C terminus enclosed
by its B subunit ring would be described as consisting of a cen-
trally aligned A2 a helix exactly matched in size to the hydropho-
bic half of the pore that then transitions into a looser strand-like
structure, with a smaller diameter, that may be poorly defined at
the pore’s membrane-proximal end (see Figure 5). The A2
segment of Ecx is unorthodox for two reasons: first, the A sub-
units activating intramolecular disulfide resides immediately
above the pore, with Cys-271 being the N-capping residue of a
short A2 helix (see Figure 3B); second, instead of forming an a
helix at the center of the pore, it is the first toxin to contain an
off-center 310 helix that does not completely fill the space pro-
vided (see Figure 3A).
An average a helix is 12 A˚ in diameter including side chains;
this provides an almost perfect match to the diameter of the B
subunit’s pentameric pore. The off-center orientation andAll rights reserved
Figure 4. The GM1 Binding Site in Ecx and Ctx
(A) The residues making up the GM1 binding site of the EcxB subunit are
presented (EcxB3 molecule shown). Black dotted lines represent hydrogen
bond interactions made between the protein and GM1. Components of the s2
s3 loop from the adjacent monomer provide additional van der Waals contacts
but are excluded for the sake of clarity. The composite OMITmap contoured at
1.5 s displays the representative density into which GM1 was built.
(B) For comparison, the equivalent orientation of the previously solved GM1
binding site within the cholera toxin (Merritt et al., 1997) and the chemical
structure of GM1 are shown.
(C) Percentage of maximal response obtained from the surface plasmon
resonance binding curves for EcxAB binding to GM1. Data represent two in-
dependent experiments performed in duplicate. Error is represented as SEM.
(D) For reference, the chemical structure of GM1.
See also Figure S4 and 3D Molecular Model S2.
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cally different interactions with the different EcxB subunits. The
A2 helix itself is eight residues long and alternates between large
hydrophobic residues on one side and small glycine or alanine
residues on the other. Inside the pore, the large hydrophobic
leucine and phenylalanine residues pack against the three
Phe-99 side chains of subunits EcxB1, B2, andB5 (see Figure 3B).
The EcxA:EcxB complex is stabilized further by polar contacts to
the C termini of helix 2 in EcxB5, B3, and B4 (see Figures 3B and
3C). The charged hydrogen bonds made by Arg-207 and Arg-
209 with the backbone of EcxB4 are particularly interesting, as
Cys-208 is the other half of the activating disulfide. Thus, the
two cystines of the EcxA intramolecular disulfide are located
next to major elements of the EcxA:EcxB interface: the A2 helix
for Cys-271 and the s11 arginine loop for Cys-208. AB5 toxins
usually contain an A1-A2 linking intramolecular disulfide that is
reduced following internalization, resulting in dissociation of
the A subunit and its activation. The integral nature of the disul-
fide within the EcxAB intersubunit interface makes it easy to see
how its reduction could promote such dissociation.Moreover, as
the s11 arginine loop lies beneath the catalytic zinc ion of EcxA
within the zinc-motif/Met turn loop, this could also provide a
means by which dissociation could affect activation of the
peptidase.
EcxB and CtxB show 63% sequence identity and almost com-
plete structural homology, yet their A subunits are distinct. How
is it possible for a commonB subunit usage to exist in the cholera
and Ecx families of toxins? Prior to the structure of Ecx, the
sequence homology of AB5 toxins indicated that they existed
as closely matched pairs, coevolving a highly stable interaction
mechanism. There are only three residue differences between
EcxB and CtxB within their respective A subunit binding sites.
Despite this, the two pentamers carry completely unrelated
cargo proteins attached through divergent A2 interaction
mechanisms. The three substitutions in EcxB/CfxB correspond
to Gly-101, Phe-99, and Ala-96 (respectively, Glu-79, Leu-77,
and Ile-74 in Ctx; see Figure S1). These residues are all part of
the hydrophobic mouth of the pentameric pore, and mutational
studies have proven their equivalents to be important for A sub-
unit binding in CtxB (Tinker et al., 2003). Apart from its A2 helix,
the intersubunit interactions of EcxA are mostly made with back-
bone groups of EcxB (see Figure 3B). Providing that pentaradiate
symmetry is maintained, many residue changes could thus
potentially be tolerated within the B subunit using an A2 310 helix
interface. The presence of Ala-96 in EcxB instead of the CtxB13, November 5, 2013 ª2013 Elsevier Ltd All rights reserved 2009
Figure 5. Organization of the AB5 Toxin
Classes
Four AB5 toxin classes have been defined via
shared sequence relationships in both their A and
B subunits. The structures of known AB5 hol-
otoxins divided into their respective classes are
displayed using the same colors for subunits with
sequence homology. The pentameric B subunit is
shown using a partially transparent surface rep-
resentation. The A subunits with cartoon repre-
sentations in which the A2 domain is highlighted in
pink are shown. The activating disulfide is shown
using a yellow dot.
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binding mode of the 310 helix. However, the converse does not
appear to be true, as LT-IIb binds its A2 helix with an Ala in this
position. Chimeric AB5 toxins prove that residue changes in
the A2 region can alter holotoxin stability and may be all that
lies between the potency differences of cholera and heat-labile
enterotoxins (Rodighiero et al., 1999). The structure of EcxAB
suggests that such intersubunit interactions with the B subunits
of AB5 proteins are more permissive and less fine-tuned than
previously thought.
Cytotoxic Activity of EcxAB
Cytotoxicity of the EcxAB protein was examined in several cell
lines, of which the most sensitive were Chinese hamster ovary
(CHO) cells. Treatment of subconfluent CHO monolayers with
5 mg/ml EcxAB holotoxin induced a pronounced cell rounding
effect after 24 hr incubation. This effect was dependent on the
presence of the enzymatic A subunit, as no cytopathic effect
was seen when cells were treated with a similar concentration
of EcxB (Figure 6). Cytopathic effects were not seen in Vero
(African green monkey kidney) cells treated with EcxAB (data
not shown). Differential susceptibilities of cell lines to distinct
AB5 toxins is commonplace. For example, Vero cells are highly
susceptible to both SubAB and Stx (50% cytotoxic doses in
the picogram range for both toxins), whereas CHO cells are sus-
ceptible to SubAB but refractory to Stx (Paton et al., 2004). This2010 Structure 21, 2003–2013, November 5, 2013 ª2013 Elsevier Ltd All rights reservedis attributable, at least in part, to differ-
ences in expression of the distinct
cognate glycan receptors (a2-3-linked
N-glycolylneuraminic acid glycans and
the glycolipid globotriaosyl ceramide for
SubAB and Stx, respectively) (Byres
et al., 2008; Paton and Paton, 1998).
Clearly, levels of expression of GM1 on
the surface of target cells would be ex-
pected to influence susceptibility to
EcxAB, possibly accounting for low po-
tency. However, whether a cytotoxic
phenotype is visible at the microscopic
level in a given cultured cell line is also
dependent on the physiological conse-
quences of A-subunit-mediated covalent
modification of its target molecule.
Whereas Stx and SubAB cause lethaldamage in Vero cells, other AB5 toxins may have more subtle ef-
fects. Ctx, for example, is bound and internalized by Vero cells,
confirming display of the cognate receptor GM1 (Chong et al.,
2008), but it exerts no obvious cytopathic phenotype in this
cell line. The culture supernatants of bacterial isolates express-
ing Ecx/Cfx also show low cytotoxicity in suckling mouse and
CHO cell assays (Karasawa et al., 2002). Thus, the Ecx family
may be relatively low potency toxins. Further work is ongoing
to identify the substrate(s) of EcxAB and to characterize its
mechanism of action and its transport following cellular uptake.
Conclusions
It is somewhat a dichotomy that the different AB5 toxin classes
have structurally related B subunits while their respective A sub-
unit cargos radically diverge. This has led to the hypothesis that
the B subunits evolved into an efficient cellular delivery and inter-
nalization system that became independently partnered with a
variety of toxic A subunits (Beddoe et al., 2010). The A subunits
of the different toxin classes may have convergently evolved un-
related connection systems utilizing C-terminal A2 helices and
redox-switch release mechanisms, because this is a highly
effective way for a protein to be transported into a host, sense
their surroundings, and then dissociate. The EcxAB holotoxin
structure presented here provides a prototype for a family of
AB5 toxins, one that is a partial hybrid with the cholera family
and fits this evolutionary hypothesis well. The Ecx/Cfx family of
Figure 6. Cytotoxicity of EcxAB for CHO Cells
Subconfluent CHO cells were treated with or without 5 mg/ml EcxAB or EcxB
for 24 hr and then examined microscopically. Scale bar, 200 mm.
Structure
EcxAB Is a Metzincin Cholera Family AB5 Toxin
Structure 21, 2003–20toxins is found in at least two bacterial species (Karasawa et al.,
2002) and could be present in many more. EcxB shares 63%
sequence identity to CtxB, and, structurally, the two proteins
overlay almost perfectly, indicating close evolutionary links.
This is in juxtaposition to EcxA, which is not an ADP-ribosyltrans-
ferase like previous cholera family toxins but rather is a novel
metalloprotease. Moreover, EcxA has a unique A2-interacting
domain comprising a redox-switch-linked 310 helix immediately
above the pentamer pore. The novel nature of the metzincin-
type metallopeptidase domain of EcxA and its B subunit-binding
mechanism can only mean that Ecx and Ctx toxins have inde-
pendently evolved their pairing to an ancestral cholera family B
subunit with minimal divergence since this time. Ecx toxin
presents a model for AB5 toxins that will force us to adapt our
current family definitions if drastically different toxin A subunits
can bind to almost identical B subunits. This remarkable ability
of AB5 proteins to recruit new toxic payloads is demonstrated
in an even more ad hoc manner in the case of the Typhoid toxin
(Song et al., 2013); this toxin consists of a Pertussis-like AB5
heterohexamer but one in which a second catalytic subunit is
added on to the first pentamer-inserting A subunit through the
evolution of a novel intermolecular disulfide crosslink.
The isolated B subunit structure of the C. freundii CfxAB is
homologous to that of EcxB (Jansson et al., 2010). However,
while Jansson et al. characterized the specificity of CfxB, they
were unclear whether they had correctly identified the CfxA
subunit, as its A2 domain shared no homology with Ctx or LT-I.
The sequence identity between CfxA and EcxA allows us to
conclude that not only is it a toxilysin metallopeptidase, but
also that it would bind to its B subunit utilizing an A2 310 helix.
Experiments are being performed to determine any posttran-
scriptional steps required for activation of this family of AB5 toxin
metalloproteases and which host proteins are their substrates.
The Ecx toxin family was identified from bacterial isolates of
patients with clinical diarrhea due to its B subunit’s relationship
to CtxB (Karasawa et al., 2002). Despite this, the enzymatic A
subunit normally thought of as responsible for disease causation
is not conserved. This raises some unusual questions: Does
EcxA induce secretory diarrhea by increasing Cl efflux through
an independent cellular pathway? If so, why would Ecx and Ctx,
two distinct toxins identified by linked disease pathology, share a
common B subunit cargo carrier? Is this a case of multiple bac-
terial strains occupying common environmental niches leading
to horizontal gene transfer, and, if so, how rapid is this process?
Rates of cholera infection are greatly reduced following im-
mune stimulation by the inactivated whole cell/recombinant B
subunit vaccine. This vaccine is targeted toward V. cholerae
infection yet also provides a measure of protection against en-
terotoxigenic E. coli due to homology between the two toxins’
B subunits (Torrell et al., 2009). The vaccine’s makeup may be
even more fortuitous if cholera-like B subunits are found in clin-
ically relevant pathogens utilizing AB5 toxins with distinct cata-
lytic domains.EXPERIMENTAL PROCEDURES
Cloning, Expression, and Purification of a Soluble Form of EcxAB
Detailed methods used for the cloning, overexpression, purification, and crys-
tallization of soluble EcxAB have been published previously (Ng et al., 2013).13, November 5, 2013 ª2013 Elsevier Ltd All rights reserved 2011
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B21(DE3) then purified by a combination of immobilized metal affinity and size
exclusion chromatography.
Cloning, Expression, and Purification of a Refolded Form of EcxAB
Two gene constructs for EcxA and EcxB, containing their respective native
signal sequence, were synthesized by GenScript. The EcxA construct con-
tained NcoI and NotI restriction sites at the N and C termini, respectively,
with these sites used to subclone from the pUC57 cloning vector into the
MCS1 of the pETDuet-1 expression vector (Novagen). The EcxB construct
contained NdeI and XhoI restriction sites at the N and C termini, respectively,
with these sites used to subclone from the pUC57 cloning vector into the
MCS2 of the pETDuet-1 expression vector.
The EcxA- and EcxB-encoding plamids were transformed into E. coli
BL21(DE3) cells following sequence verification, and EcxA and EcxB were ex-
pressed in an insoluble form as inclusion bodies. The cells were grown in Luria
broth containing 100 mg/ml ampicillin to an optical density 600 of 0.6.
BL21(DE3) cells were induced by the addition of 1.5 mM isopropyl-b-D-1-thi-
ogalactopyranoside for 4 hr. Cell culture pellet was collected following centri-
fugation at 5000 3 g for 20 min at 4C, resuspended in Tris-buffered saline,
and stored at 20C. The cell pellet was thawed, lysed using a cell disruptor
(Avestin), and centrifuged at 30,000 3 g for 30 min at 4C. Inclusion bodies
were washed twicewith 50mMTris-HCl, pH 8, 100mMNaCl, 1mM b-mercap-
toethanol, 0.2 mM phenylmethanesulfonylfluoride (PMSF), 0.5% Triton X-100,
and then washed once with 50 mM Tris-HCl, pH 8, 1 mM b-mercaptoethanol,
0.2 mM PMSF. Following washing, the inclusion bodies were dissolved in
20 ml resolubilization buffer containing 6 M guanidine hydrochloride,
100 mM Tris-HCl, pH 8, 5 mM b-mercaptoethanol. The solubilized pellet
was slowly diluted into 2 l refold buffer containing 50 mM Tris-HCl, pH 8,
500 mMNaCl, 5 mM imidazole and stirred overnight at room temperature. Pu-
rification of the refolded form of EcxAB is as described for the soluble form.
Cytotoxicity Assay
Cytotoxocity assays were performed using CHO and Vero cells, as described
elsewhere (Paton et al., 2004).
Crystallization and Data Analysis
Apo Form of EcxAB
Crystals were grown using the hanging-drop, vapor-diffusion method, with a
1:1 (v/v) ratio of EcxAB to mother liquor (well volume, 1 ml). Appearance of
crystals from the soluble form of EcxAB occurred within 3 days in 4% tacsi-
mate, pH 4.5, 10% polyethylene glycol 3350. Crystals were flash-frozen in
liquid nitrogen before data collection with 20% glycerol as the cryoprotectant.
EcxAB with GM1 Pentasaccharide Bound
Crystals were grown using the hanging-drop, vapor-diffusion method, with a
1:1 (v/v) ratio of EcxAB to mother liquor (well volume, 1 ml). Appearance of
crystals from the refolded form of EcxAB occurred within 3 days in 0.8 M
NaH2PO4, 0.8 M KH2PO4, 0.1 M HEPES Na, pH 7.5. GM1 pentasaccharide
(Enzo Life Sciences) was added so that the final concentration was approxi-
mately 10 mM in drops containing preformed crystals. GM1 was allowed to
soak into these crystals for 3 days before flash-freezing in liquid nitrogen
and subsequent data collection, using 2 M CH3CO2K as the cryoprotectant.
Structure Determination
All diffraction data were collected at 100K on beamline MX2 of the Australian
synchrotron. Diffraction data from crystals of the apo- and GM1-soaked
EcxAB were obtained at 1.86 A˚ and 1.80 A˚, respectively. The crystals belong
to the spacegroup P6522 and contain one molecule in the asymmetric unit.
The structure of apo EcxAB was obtained using a single chain of CtxB (Merritt
et al., 1997) (PDB ID 2CHB) as a molecular replacement model in the program
PHASER (McCoy, 2007;McCoy et al., 2007). As no close homolog of the A sub-
unit was initially identified, ARP/wARP (Langer et al., 2008; Murshudov et al.,
2011) was used to build a starting model for the A subunit. A largely complete
holotoxin structure resulted, followed by rounds of manual building and refine-
ment. Model building and structural validationwere completed using theCCP4
suite (Winn et al., 2011), PHENIX (Adams et al., 2010), and Coot (Emsley et al.,
2010). Solvent molecules were retained only if they had acceptable hydrogen
bonding geometry contacts of 2.5 A˚–3.5 A˚ with protein atoms or with existing2012 Structure 21, 2003–2013, November 5, 2013 ª2013 Elsevier Ltdsolvent and were in good 2Fo  Fc electron density. The final holotoxin model
consists of residues 22–126 from five EcxB molecules, residues 21–67, 72–
102, and 108–282 from EcxA and a Zinc ion. The GM1-soaked structure was
obtained using the apo EcxAB as a molecular replacement model; electron
density was clear for all sugar moieties of all five GM1 molecules. A summary
of data collection and refinement statistics is provided in Table 1.
Glycan Array Analysis
Purified EcxAB protein at 0.2 mg/ml was applied to a glycan microarray slide at
the CFG Protein-Glycan Interaction Core at Emory University. Binding was
detected using fluorescence-conjugated anti-hexahistidine antibody. The
data are reported as average relative fluorescence units of four of six replicates
(after removal of the highest and lowest values) for each glycan represented on
the array.
SPR Analysis
All SPR experiments were conducted at 25C on a BIAcore 3000 instrument
using HEPES-buffered saline (10 mM HEPES-HCl, pH 7.4, 500 mM NaCl,
and 0.005% P20 [v/v]). Biotinylated synthetic carbohydrates utilized in
the SPR studies were obtained either from the CFG Glycan Array Synthesis
Core or GlycoTech. The biotinylated glycans—CH2CH2NH2-biotin (Sp0),
Galb(1-4)-Glca-Sp0-biotin, GM1-Sp0-biotin, and aNeu5Ac-Sp0-biotin—
were immobilized on an SA-Chip (GE Healthcare) with a surface density of
approximately 200 response units. Various concentrations of EcxAB (1.17 to
350 nM) were injected over the captured glycans at 10 ml/min. The surface
was regenerated with two injections of 4 MMgCl2 at 100 ml/min between injec-
tions of EcxAB. The final response was calculated by subtracting the response
of the blank flow cell alone (Sp0) from the EcxAB-glycan complex. The equilib-
rium data were analyzed using GraphPad Prism.
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